Michaeli, D., Mills, M., & Kanavos, P. (2022). Value and price of multi-indication cancer drugs in the USA, Germany, France, England, Canada, Australia, and Scotland. Applied health economics and health policy, 20(5), . https://doi.org/10.1007/s40258-022-00737-w
Chicago Style (17th ed.) CitationMichaeli, Daniel, Mackenzie Mills, and Panos Kanavos. "Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland." Applied Health Economics and Health Policy 20, no. 5 (2022). https://doi.org/10.1007/s40258-022-00737-w.
MLA (9th ed.) CitationMichaeli, Daniel, et al. "Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland." Applied Health Economics and Health Policy, vol. 20, no. 5, 2022, https://doi.org/10.1007/s40258-022-00737-w.